Given the functional connection between αvβ3 and αvβ5 signaling, NF-κB signaling, and invasive phenotypes in cancer, we tested if integrin signaling inhibition could reverse the increase in phenotypes of aggression that we found with ATRX knockdown/KO. The gene discussed is ATRX; the disease is cancer.